Fairbanks, LD; Levene, M; Bax, BE
(2013)
Validation of a HPLC method for the measurement of erythrocyte encapsulated thymidine phosphorylase (EE-TP) activity.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 76.
8 - 12.
ISSN 0731-7085
https://doi.org/10.1016/j.jpba.2012.12.006
SGUL Authors: Bax, Bridget Elizabeth
![]() |
["document_typename_application/zip; charset=binary" not defined]
Submitted Version
Download (49kB) |
Abstract
A sensitive and simple reverse-phase high performance liquid chromatographic (HPLC) assay has been validated for the determination of thymine as a measure of thymidine phosphorylase activity encapsulated in erythrocytes (EE-TP), a formulation which is under clinical development as an enzyme replacement therapy for the treatment of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Diluted erythrocyte lysates were incubated in 100 mM sodium phosphate buffer and 10 mM thymidine at 37 °C for 10 min and the reaction stopped with 40% trichloroacetic acid. Following centrifugation, the supernatant was washed with water saturated diethyl ether, and injected onto a Spherisorb C18 column (125 mm × 4.6 mm, 5 μm), with a mobile phase (40 mM ammonium acetate, 5 mM tetrabutyl ammonium hydrogen sulphate, pH 2.70) delivered at a flow rate of 1.0 ml/min and run time of 8 min. Ultraviolet detection (UV) was employed at 254 nm. The method was linear in the range of 5–500 nmol/ml (r2 = 0.992), specific with intra- and inter-day precisions of <9.6 and accuracies within ±20%. Limits of detection and quantification were 1.2 nmol/ml and 10 nmol/ml, respectively. The method was applied to quantify thymidine phosphorylase activity in samples of in-process controls and batches of EE-TP manufactured for clinical use
Item Type: | Article | ||||
---|---|---|---|---|---|
Additional Information: | NOTICE: this is the author’s version of a work that was accepted for publication in Journal of Pharmaceutical and Biomedical Analysis . Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in the Journal of Pharmaceutical and Biomedical Analysis [76, 25 March 2013] 10.1016/j.jpba.2012.12.006 | ||||
Keywords: | Chromatography, High Pressure Liquid, Chromatography, Reverse-Phase, Erythrocytes, Humans, Limit of Detection, Sensitivity and Specificity, Thymidine, Thymidine Phosphorylase, Science & Technology, Physical Sciences, Life Sciences & Biomedicine, Chemistry, Analytical, Pharmacology & Pharmacy, Chemistry, CHEMISTRY, ANALYTICAL, PHARMACOLOGY & PHARMACY, HPLC, Thymidine phosphorylase, Erythrocyte encapsulated thymidine phosphorylase, Validation, MNGIE, MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY, ADENOSINE-DEAMINASE, BLOOD-CELLS, IN-VIVO, DEFICIENCY, DRUGS, ASSAY, Analytical Chemistry, 0301 Analytical Chemistry, 1115 Pharmacology And Pharmaceutical Sciences | ||||
SGUL Research Institute / Research Centre: | Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Cell Sciences (INCCCS) |
||||
Journal or Publication Title: | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | ||||
ISSN: | 0731-7085 | ||||
Related URLs: | |||||
Dates: |
|
||||
Web of Science ID: | WOS:000315065500002 | ||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/107130 | ||||
Publisher's version: | https://doi.org/10.1016/j.jpba.2012.12.006 |
Statistics
Actions (login required)
![]() |
Edit Item |